Tooru (LSE:TOO.L), an AIM-listed branded health and wellness group, said in a trading update that its operating subsidiaries are expected to deliver a strong EBITDA performance for 2025 in line with management's expectations and that momentum has continued into the first quarter of 2026 with monthly average gross revenue of around £1 million and EBITDA of £150,000.
Its Juvela and OAF brands are cited as the main drivers of that momentum, with OAF launching in Asda where initial sales are tracking ahead of expectations and introducing new Softie Sub Rolls into Tesco, while Pulsin has returned to growth after a period of consolidation with new capital investment, a contract manufacturing arrangement and improved margins.
"We are seeing encouraging momentum across the Group, with strong EBITDA delivery, growing revenues and excellent progress from both Juvela and OAF," said Scott Livingston, CEO.
The company has signed terms for the potential acquisition of Mylky and is exploring various debt funding structures to effect the transaction, which includes the issue of Tooru shares at 0.77p per share versus the current share price of 0.19p, and the Board believes the deal could add significant scale and earnings capability to the Group.
The Board says current trading provides a solid platform for continued growth through 2026.
